Company Facts
About Owkin
Owkin applies AI to medical research, using federated learning to analyze health data while preserving privacy to accelerate clinical insights.
What is Owkin?
Owkin is an AI biotech company focused on unlocking complex biology to find the right treatment for every patient. It combines advanced AI technologies with biological reasoning to enhance drug discovery and development.
Who is Owkin for?
Owkin primarily serves pharmaceutical companies and healthcare providers looking to enhance drug discovery, clinical trials, and diagnostic accuracy through advanced AI technologies.
When was Owkin founded?
Owkin was founded in 2016, marking its entry into the biotechnology sector with a focus on AI applications in healthcare.
Who founded Owkin?
Owkin was founded by Thomas Clozel, MD, a clinical research doctor, and Gilles Wainrib, PhD, a pioneer in machine learning applied to biology.
What is Owkin best known for?
Owkin is best known for its innovative AI-driven solutions that enhance drug discovery and precision diagnostics, particularly through its K Pro platform.
Where AI Leaders Stay Informed
The latest AI intelligence, case studies, and research — delivered to your inbox every week.
Free to read. Unsubscribe anytime.
Is this your company?
Claim this profile to manage information and unlock premium features.